FMP
CYTK icon

Financial Management Professionals’s Cytokinetics CYTK Stock Holding History

Financial Management Professionals’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937 Hold
11
– – ﹤0.01% 873
2026
Q1 		$725 Buy
11
+6
+120% +$381 ﹤0.01% 841
2025
Q4 		$318 Hold
5
– – ﹤0.01% 916
2025
Q3 		$275 Buy
+5
New +$206 ﹤0.01% 908
2025
Q2 		– Sell
-5
Closed -$201 – 1031
2025
Q1 		$201 Buy
+5
New +$230 ﹤0.01% 954
2024
Q4 		– Sell
-7
Closed – – 1005
2024
Q3 		$0 Buy
7
+2
+40% +$111 ﹤0.01% 950
2024
Q2 		$0 Buy
+5
New +$302 ﹤0.01% 913

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Management Professionals's CYTK Position: Q2 2026 in Review

Financial Management Professionals held its Cytokinetics (CYTK) position steady in Q2 2026 at 11 shares worth $937. The position accounts for ﹤0.01% of the portfolio, ranked #873.

Financial Management Professionals first reported a position in CYTK in Q2 2024 and has held it in 7 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Financial Management Professionals held 11 shares of Cytokinetics worth $937 as of Q2 2026.
  • Financial Management Professionals left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #873 holding.
  • Financial Management Professionals first reported a position in Cytokinetics in Q2 2024 and has held it in 7 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.